Atara Biotherapeutics Inc share price logo

Atara Biotherapeutics Inc Share Price

NASDAQ: ATRA

Small Cap

$4.86

-0.05

(-1.02%)

as on

Atara Biotherapeutics Inc Stock Performance

as on March 24, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.76
    $5.03
    downward going graph

    2.06%

    Downside

    3.50%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.92
    $19.15
    downward going graph

    19.34%

    Downside

    293.93%

    Upside

    downward going graph

Atara Biotherapeutics Inc share price movements today

Previous Close
$4.91
Open
$5.00
Volume
199.0K
Day's Low - High
$4.76 - $5.03
52 Week Low - High
$3.92 - $19.15

Atara Biotherapeutics Inc Historical Returns

1 Month Return
+ 16.9 %
3 Month Return
-71.94 %
1 Year Return
-25.94 %
3 Year Return
-93.13 %
5 Year Return
-98.67 %

Atara Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check Atara Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$40.2M

EPS (TTM)

-1.45

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

1.91

Industry PE ratio

-4.738881355932204

PEG Ratio

0

EBITDA

51.6M

Revenue (TTM)

120.8M

Profit Margin

27.07%

Return On Equity TTM

-2014.86%

Atara Biotherapeutics Inc Stock Valuation

Track how Atara Biotherapeutics Inc P/E has moved over time to understand its valuation trends.

Atara Biotherapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-115.97x)

December 31, 2021

Industry (-4.74x)

March 23, 2026

Today (1.91x)

March 23, 2026

Highest (5.28x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 1.91x

Atara Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Atara Biotherapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Atara Biotherapeutics Inc image
Atara Biotherapeutics Inc
BUY$40.2M-98.67%1.9127.07%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B125.13%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.56%29.6732.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B56.01%17.6731.41%

Stock Returns calculator for Atara Biotherapeutics Inc Stock including INR - Dollar returns

The Atara Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Atara Biotherapeutics Inc investment value today

Current value as on today

₹83,223

Returns

₹16,777

(-16.78%)

Returns from Atara Biotherapeutics Inc Stock

₹26,697 (-26.7%)

Dollar Returns*

₹9,919 (+9.92%)

Analyst Recommendation on Atara Biotherapeutics Inc Stock

Based on 13 analysts

BUY

61.54%

Buy

30.77%

Hold

7.69%

Sell

Based on 13 analysts, 61.54% of analysts recommend a 'BUY' rating for Atara Biotherapeutics Inc. Average target price of $5

Atara Biotherapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Atara Biotherapeutics Inc.

What analysts predicted

2.8%UPSIDE

Target Price

$5

Current Price

$4.86

Analyzed by

13 Analysts

Target

$5.00

Atara Biotherapeutics Inc target price $5, a slight upside of 2.8% compared to current price of $4.86. According to 13 analysts rating.

Atara Biotherapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Atara Biotherapeutics Inc Stock has increased by 36% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:36% versus previous 30 day period

Atara Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
2
4
27
28
40
32
98
17
3
1
Gross Profit
0
1
25
24
32
25
77
17
3
1
Operating Income
-69
-53
-31
-18
-21
-12
38
3
-3
-2
EBITDA
-67
-58
-29
-16
-19
-10
40
3
-3
-3
Interest Expense
1
1
1
1
1
1
1
0
0
0
Depreciation
1
1
1
1
1
1
1
0
0
0
Income Before Tax
-69
-60
-31
-19
-21
-12
38
2
-4
-3
Income Tax Expense
0
0
0
171
0
0
-
0
0
-
Net Income
-69
-60
-31
-19
-21
-12
38
2
-4
-3
Net Profit Margin
-3264.59%
-1421.68%
-116.07%
-66.51%
-54.51%
-38.75%
38.73%
13.58%
-124.62%
-213.54%

Atara Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
3
20
63
8
128
120
Gross Profit
0
0
-3
-8
-9
20
63
0
107
99
Operating Income
-81
-121
-237
-295
-309
-340
-280
-276
-83
35
EBITDA
-80
-120
-233
-288
-300
-331
-222
-265
-75
50
Interest Expense
-
-
-
11
10
9
0
5
4
3
Depreciation
-
0
3
7
8
9
5
4
5
2
Income Before Tax
-79
-119
-230
-290
-306
-340
-228
-276
-85
32
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-79
-119
-230
-290
-306
-340
-228
-276
-85
32
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-8632.32%
-1672.28%
-359.12%
-3220.88%
-66.23%
27.07%

Atara Biotherapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-60
-31
-19
-21
-12
38
2
-4
-3
Operating Cash Flow
-50
-29
-10
-3
-24
-28
-7
-9
-5
Investing Cash Flow
9
14
7
-16
3
17
-5
-2
8
Financing Cash Flow
1
24
0
35
0
0
15
1
0
Change in Cash
-38
9
-3
15
-21
-11
2
-11
2

Atara Biotherapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-119
-230
-290
-306
-340
-228
-276
-85
32
Operating Cash Flow
-87
-179
-235
-180
-220
-270
-192
-68
-50
Investing Cash Flow
98
-196
60
-120
22
202
123
8
18
Financing Cash Flow
20
357
188
427
103
53
2
59
16
Change in Cash
31
-18
13
126
-94
-14
-67
0
-16

Global Institutional Holdings in Atara Biotherapeutics Inc

Funds
Holdings
Quadrature Capital Limited
0.28%
Point72 Asset Management, L.P.
0.25%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.
0.24%
Redmile Group, LLC
6.03%
Bank of America Corp
0.11%
See all

Insights on Atara Biotherapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -4.30M → -3.40M (in $), with an average increase of 26.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 11.3% return, outperforming this stock by 37.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Atara Biotherapeutics Inc has experienced a drawdown of -93.1%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 84.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ATRA stock has moved down by -16.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 98.14M → 1.59M (in $), with an average decrease of 72.1% per quarter

About Atara Biotherapeutics Inc

we launched atara biotherapeutics in august 2012 to help patients combat cancer, kidney disease and other illnesses. our research is based on groundbreaking discoveries regarding the ability of activin, myostatin and other growth factors to change the course of disease progression. our goal is to help patients such as atara ciechanover, our company’s namesake, who suffered from cancer before passing away in 2012. we aim to empower patients to fight their illnesses with better treatment options. atara biotherapeutics is developing several innovative product candidates, including pinta 745, stm 434 and ata 842, and is collaborating with memorial sloan kettering cancer center (msk) in the development of three t-cell product candidates: epstein-barr virus (ebv)-targeted cytotoxic t lymphocytes (ctls), cytomegalovirus (cmv)-targeted ctls, and wilms tumor 1 (wt1)-targeted ctls. each product candidate is designed to address the underlying mechanisms of disease to treat conditions which have
OrganisationAtara Biotherapeutics Inc
Headquarters1280 Rancho Conejo Blvd, Thousand Oaks, CA, United States, 91320
IndustryHealth Technology
CEODr. Anhco Nguyen Ph.D.
E-voting on sharesClick here to vote

Key Management of Atara Biotherapeutics Inc

Name

Title

Ms. Yanina Grant-Huerta

Chief Accounting Officer & Principal Accounting Officer

Alex Chapman

Vice President of Corporate Communications & Investor Relations

Mr. John Chao

Head of Legal

Mr. Jim Sesic

Senior Vice President of Regulatory Affairs

Dr. Anhco Nguyen Ph.D.

President, CEO & Director

FAQs

What is Atara Biotherapeutics Inc share price today?

Atara Biotherapeutics Inc share price today is $4.86 as on at the close of the market. Atara Biotherapeutics Inc share today touched a day high of $5.03 and a low of $4.76.

What is the 52 week high and 52 week low for Atara Biotherapeutics Inc share?

Atara Biotherapeutics Inc share touched a 52 week high of $19.15 on and a 52 week low of $3.92 on . Atara Biotherapeutics Inc stock price today i.e. is closed at $4.86,which is 74.61% down from its 52 week high and 23.98% up from its 52 week low.

What is Atara Biotherapeutics Inc's market capitalisation today?

Atara Biotherapeutics Inc market capitalisation is $0.00T as on .

How to invest in Atara Biotherapeutics Inc Stock (ATRA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Atara Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Atara Biotherapeutics Inc Shares that will get you 0.3086 shares as per Atara Biotherapeutics Inc share price of $4.86 per share as on March 24, 2026 at 1:29 am IST.

What is the minimum amount required to buy Atara Biotherapeutics Inc Stock (ATRA) from India?

Indian investors can start investing in Atara Biotherapeutics Inc (ATRA) shares with as little as ₹94.058 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.58 in Atara Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Atara Biotherapeutics Inc share’s latest price of $4.86 as on March 24, 2026 at 1:29 am IST, you will get 2.0576 shares of Atara Biotherapeutics Inc. Learn more about fractional shares .

What are the returns that Atara Biotherapeutics Inc has given to Indian investors in the last 5 years?

Atara Biotherapeutics Inc stock has given -98.67% share price returns and 29.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?